Bio Rad Stock Options
| BIO Stock | USD 256.68 2.21 0.87% |
Bio Rad's latest option contracts expiring on June 20th 2025 are carrying combined implied volatility of 0.57 with a put-to-call open interest ratio of 0.83 over 49 outstanding agreements suggesting investors are buying slightly more calls than puts on contracts expiring on June 20th 2025.
Open Interest Against June 20th 2025 Option Contracts
2025-06-20
The chart above shows Bio Rad's distribution of open interest by maturity on contracts that have not yet been settled. The area between the two highest points is the projection of the price at expiration. Bio Rad's open interest chart also provides vital information regarding the liquidity of an option. If there is no open interest for Bio Rad's option, there is no secondary market available for investors to trade.
Bio Rad Maximum Pain Price Across 2025-06-20 Option Contracts
Max pain occurs when Bio Rad's market makers reach a net positive position across all Bio Rad's options at a strike price where option holders stand to lose the most money. By contrast, Bio Rad's option sellers may reap the most after selling more options than buying, causing them to expire worthless.
In The Money vs. Out of Money Option Contracts on Bio Rad
Analyzing Bio Rad's in-the-money options over time can help investors to take a profitable long position in Bio Rad regardless of its overall volatility. This is especially true when Bio Rad's options are deep in the money. These options can be identified using deltas that are over 0.75. Deep in-the-money Bio Rad's options could be used as guardians of the underlying stock as they move almost dollar for dollar with Bio Rad's stock while costing only a fraction of its price.
Please note that buying 'in-the-money' options on Bio Rad lessens the impact of time decay, as they carry both intrinsic and time value. So, even if Bio Rad's value remains static through the expiration date, the investor can sell to close an 'in-the-money' option to avoid a potential loss. However, in-the-money Bio Rad contracts are usually more expensive to enter than their out-of-the-money counterparts. So keep in mind that while the payoffs on an in-the-money trade can be high, the investors could ultimately experience a more consequential loss if Bio Stock moves the wrong way.
Bio Rad Laboratories In The Money Call Balance
When Bio Rad's strike price is surpassing the current stock price, the option contract against Bio Rad Laboratories stock is said to be in the money. When it comes to buying Bio Rad's options that are 'In the Money' or 'Out of the Money', the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
While 'out-of-the-money' option contracts written on Bio Rad Laboratories are typically viewed as the more aggressive, there are potential upsides to purchasing these types of options contracts. For one, the cost to buy an 'Out of the Money' option is lower than the cost to buy an 'In the Money' option. This cost-benefit is due to the fact that at the time of the purchase, 'Out of the Money' contracts have no intrinsic value. So, while the potential for a 100% loss is more significant, the cost and risk to enter the trade are lower.
Bio Current Options Market Mood
Bio Rad's open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps Bio Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.
Put-to-Call Open Interest
Put-to-Call Volume
Unfortunately, most Bio Rad's options investors are not very successful. Bio Rad's option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction.
Rule 16 of the current Bio contract
Base on the Rule 16, the options market is currently suggesting that Bio Rad Laboratories will have an average daily up or down price movement of about 0.0356% per day over the life of the 2025-06-20 option contract. With Bio Rad trading at USD 256.68, that is roughly USD 0.0914. If you think that the market is fully incorporating Bio Rad's daily price movement you should consider buying Bio Rad Laboratories options at the current volatility level of 0.57%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Bio |
Purchasing Bio Rad options can give investors a meaningful hedge against losses and, therefore, could be used conservatively to decrease the volatility of your portfolio. However, many options could also amount to little more than gambling, significantly enhancing your overall portfolio risk. One simple example of these aggressive strategies is the sale of "uncovered" Bio calls. Remember, the seller must deliver Bio Rad Laboratories stock to the call owner when a call is exercised.
Bio Rad Option Chain
When Bio Rad's strike price is surpassing the current stock price, the option contract against Bio Rad Laboratories stock is said to be in the money. When it comes to buying options that are ITM or OTM, the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
Bio Rad's option chain is a display of a range of information that helps investors for ways to trade options on Bio. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for Bio. It also shows strike prices and maturity days for a Bio Rad against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone. | Open Int | Strike Price | Current Spread | Last Price | |||
Call | BIO250620C00540000 | 18 | 540.0 | 0.1 - 0.7 | 0.85 | Out |
Call | BIO250620C00520000 | 1 | 520.0 | 0.0 - 4.8 | 0.8 | Out |
Call | BIO250620C00500000 | 0 | 500.0 | 0.0 - 4.8 | 4.8 | |
Call | BIO250620C00490000 | 0 | 490.0 | 0.0 - 4.8 | 4.8 | |
Call | BIO250620C00480000 | 0 | 480.0 | 0.0 - 4.8 | 4.8 | |
Call | BIO250620C00470000 | 0 | 470.0 | 0.0 - 4.8 | 4.8 | |
Call | BIO250620C00460000 | 0 | 460.0 | 0.0 - 4.8 | 4.8 | |
Call | BIO250620C00450000 | 0 | 450.0 | 0.0 - 4.8 | 4.8 | |
Call | BIO250620C00440000 | 0 | 440.0 | 0.0 - 4.8 | 4.8 | |
Call | BIO250620C00430000 | 0 | 430.0 | 0.0 - 4.8 | 4.8 | |
Call | BIO250620C00420000 | 1 | 420.0 | 0.0 - 4.8 | 10.0 | Out |
Call | BIO250620C00410000 | 1 | 410.0 | 0.0 - 4.8 | 6.7 | Out |
Call | BIO250620C00400000 | 8 | 400.0 | 0.0 - 4.8 | 13.74 | Out |
Call | BIO250620C00380000 | 1 | 380.0 | 0.0 - 4.8 | 4.55 | Out |
Call | BIO250620C00370000 | 3 | 370.0 | 0.0 - 4.8 | 3.8 | Out |
Call | BIO250620C00360000 | 8 | 360.0 | 0.0 - 4.8 | 1.75 | Out |
Call | BIO250620C00350000 | 2 | 350.0 | 0.0 - 4.8 | 22.0 | Out |
Call | BIO250620C00340000 | 2 | 340.0 | 0.0 - 4.8 | 2.4 | Out |
Call | BIO250620C00330000 | 1 | 330.0 | 0.05 - 10.0 | 8.5 | Out |
Call | BIO250620C00320000 | 4 | 320.0 | 0.05 - 10.0 | 6.7 | Out |
Call | BIO250620C00310000 | 5 | 310.0 | 0.05 - 10.0 | 5.96 | Out |
Call | BIO250620C00300000 | 5 | 300.0 | 0.1 - 10.0 | 6.65 | Out |
Call | BIO250620C00280000 | 6 | 280.0 | 6.0 - 14.5 | 26.9 | Out |
Call | BIO250620C00270000 | 19 | 270.0 | 13.0 - 17.0 | 14.8 | Out |
Call | BIO250620C00250000 | 3 | 250.0 | 21.2 - 28.0 | 25.0 | In |
Put | BIO250620P00540000 | 0 | 540.0 | 279.0 - 288.4 | 279.0 | In |
Put | BIO250620P00520000 | 0 | 520.0 | 259.0 - 268.6 | 259.0 | In |
Put | BIO250620P00500000 | 0 | 500.0 | 239.0 - 248.4 | 239.0 | In |
Put | BIO250620P00490000 | 0 | 490.0 | 229.0 - 238.5 | 229.0 | In |
Put | BIO250620P00480000 | 0 | 480.0 | 219.0 - 228.6 | 219.0 | In |
Put | BIO250620P00470000 | 0 | 470.0 | 209.0 - 218.6 | 209.0 | In |
Put | BIO250620P00460000 | 0 | 460.0 | 199.0 - 208.5 | 199.0 | In |
Put | BIO250620P00450000 | 0 | 450.0 | 189.0 - 198.6 | 189.0 | In |
Put | BIO250620P00440000 | 0 | 440.0 | 179.0 - 188.7 | 179.0 | In |
Put | BIO250620P00430000 | 0 | 430.0 | 169.0 - 178.8 | 169.0 | In |
Put | BIO250620P00340000 | 1 | 340.0 | 79.0 - 88.3 | 23.5 | In |
Put | BIO250620P00310000 | 15 | 310.0 | 52.4 - 60.0 | 35.12 | In |
Put | BIO250620P00300000 | 10 | 300.0 | 43.5 - 51.0 | 10.5 | In |
Put | BIO250620P00290000 | 10 | 290.0 | 35.5 - 44.0 | 7.77 | In |
Put | BIO250620P00280000 | 15 | 280.0 | 28.3 - 37.0 | 19.25 | In |
Put | BIO250620P00270000 | 2 | 270.0 | 22.2 - 31.0 | 10.6 | In |
Put | BIO250620P00260000 | 3 | 260.0 | 17.3 - 24.9 | 19.62 | In |
Put | BIO250620P00250000 | 10 | 250.0 | 13.7 - 21.0 | 18.5 | Out |
Put | BIO250620P00200000 | 1 | 200.0 | 0.05 - 6.8 | 2.05 | Out |
Put | BIO250620P00190000 | 1 | 190.0 | 0.2 - 10.0 | 3.1 | Out |
Put | BIO250620P00185000 | 2 | 185.0 | 0.0 - 4.8 | 2.0 | Out |
Put | BIO250620P00180000 | 1 | 180.0 | 0.0 - 4.8 | 1.7 | Out |
Put | BIO250620P00170000 | 1 | 170.0 | 0.0 - 4.8 | 1.25 | Out |
Put | BIO250620P00165000 | 1 | 165.0 | 0.0 - 4.8 | 1.05 | Out |
Bio Total Stockholder Equity
Total Stockholder Equity |
|
Bio Rad Corporate Directors
| Jeffrey Edwards | Independent Director | Profile | |
| Tania DeVilliers | Corporate Director | Profile | |
| Arnold Pinkston | Independent Director | Profile | |
| Alice Schwartz | Director | Profile |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bio Rad Laboratories. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.
Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bio Rad. If investors know Bio will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bio Rad listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 5.412 | Earnings Share (65.35) | Revenue Per Share | Quarterly Revenue Growth (0.02) | Return On Assets |
The market value of Bio Rad Laboratories is measured differently than its book value, which is the value of Bio that is recorded on the company's balance sheet. Investors also form their own opinion of Bio Rad's value that differs from its market value or its book value, called intrinsic value, which is Bio Rad's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bio Rad's market value can be influenced by many factors that don't directly affect Bio Rad's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Bio Rad's value and its price as these two are different measures arrived at by different means. Investors typically determine if Bio Rad is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bio Rad's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.